Meta Pixel

Company Updates

Company Updates
Imugene Ltd Starts First Patient Dosing

The leading product developed by Imugene Ltd, HER-Vaxx, has successfully completed a Phase 1 study in breast cancer and the next stage of development will be a Phase 2 study in gastric cancer.

Join over 45,000+ sophisticated investors

Join Now